Global Tumor Immunotherapy Drugs Supply, Demand and Key Producers, 2023-2029
The global Tumor Immunotherapy Drugs market size is expected to reach $ 77680 million by 2029, rising at a market growth of 8.5% CAGR during the forecast period (2023-2029).
Tumor immunotherapy refers to destroying cancer cells by stimulating and activating the patient's own immune system.
This report studies the global Tumor Immunotherapy Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Tumor Immunotherapy Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Tumor Immunotherapy Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Tumor Immunotherapy Drugs total production and demand, 2018-2029, (K Units)
Global Tumor Immunotherapy Drugs total production value, 2018-2029, (USD Million)
Global Tumor Immunotherapy Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Tumor Immunotherapy Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Tumor Immunotherapy Drugs domestic production, consumption, key domestic manufacturers and share
Global Tumor Immunotherapy Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Tumor Immunotherapy Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Tumor Immunotherapy Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Tumor Immunotherapy Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol Myer Squibb, AstraZeneca, Merck, Roche / Genentech, Ono Pharmaceutical, Regeneron, Innovent, Hengrui Medicine and Junshi Biosciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Tumor Immunotherapy Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Tumor Immunotherapy Drugs Market, By Region:
1. How big is the global Tumor Immunotherapy Drugs market?
2. What is the demand of the global Tumor Immunotherapy Drugs market?
3. What is the year over year growth of the global Tumor Immunotherapy Drugs market?
4. What is the production and production value of the global Tumor Immunotherapy Drugs market?
5. Who are the key producers in the global Tumor Immunotherapy Drugs market?
6. What are the growth factors driving the market demand?
Tumor immunotherapy refers to destroying cancer cells by stimulating and activating the patient's own immune system.
This report studies the global Tumor Immunotherapy Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Tumor Immunotherapy Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Tumor Immunotherapy Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Tumor Immunotherapy Drugs total production and demand, 2018-2029, (K Units)
Global Tumor Immunotherapy Drugs total production value, 2018-2029, (USD Million)
Global Tumor Immunotherapy Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Tumor Immunotherapy Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Tumor Immunotherapy Drugs domestic production, consumption, key domestic manufacturers and share
Global Tumor Immunotherapy Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Tumor Immunotherapy Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Tumor Immunotherapy Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Tumor Immunotherapy Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol Myer Squibb, AstraZeneca, Merck, Roche / Genentech, Ono Pharmaceutical, Regeneron, Innovent, Hengrui Medicine and Junshi Biosciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Tumor Immunotherapy Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Tumor Immunotherapy Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Immune Checkpoint Inhibitors
- Tumor Vaccine
- Adoptive Immunotherapy
- Non-specific Immunomodulator
- Hospital
- Clinic
- Other
- Bristol Myer Squibb
- AstraZeneca
- Merck
- Roche / Genentech
- Ono Pharmaceutical
- Regeneron
- Innovent
- Hengrui Medicine
- Junshi Biosciences
- Pfizer, Inc
- F. Hoffmann-La Roche Ltd
- Incyte Corporation
- NewLink Genetics Corporation
- Celldex Therapeutics, Inc
- GlaxoSmithKline
1. How big is the global Tumor Immunotherapy Drugs market?
2. What is the demand of the global Tumor Immunotherapy Drugs market?
3. What is the year over year growth of the global Tumor Immunotherapy Drugs market?
4. What is the production and production value of the global Tumor Immunotherapy Drugs market?
5. Who are the key producers in the global Tumor Immunotherapy Drugs market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Tumor Immunotherapy Drugs Introduction
1.2 World Tumor Immunotherapy Drugs Supply & Forecast
1.2.1 World Tumor Immunotherapy Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World Tumor Immunotherapy Drugs Production (2018-2029)
1.2.3 World Tumor Immunotherapy Drugs Pricing Trends (2018-2029)
1.3 World Tumor Immunotherapy Drugs Production by Region (Based on Production Site)
1.3.1 World Tumor Immunotherapy Drugs Production Value by Region (2018-2029)
1.3.2 World Tumor Immunotherapy Drugs Production by Region (2018-2029)
1.3.3 World Tumor Immunotherapy Drugs Average Price by Region (2018-2029)
1.3.4 North America Tumor Immunotherapy Drugs Production (2018-2029)
1.3.5 Europe Tumor Immunotherapy Drugs Production (2018-2029)
1.3.6 China Tumor Immunotherapy Drugs Production (2018-2029)
1.3.7 Japan Tumor Immunotherapy Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Tumor Immunotherapy Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Tumor Immunotherapy Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Tumor Immunotherapy Drugs Demand (2018-2029)
2.2 World Tumor Immunotherapy Drugs Consumption by Region
2.2.1 World Tumor Immunotherapy Drugs Consumption by Region (2018-2023)
2.2.2 World Tumor Immunotherapy Drugs Consumption Forecast by Region (2024-2029)
2.3 United States Tumor Immunotherapy Drugs Consumption (2018-2029)
2.4 China Tumor Immunotherapy Drugs Consumption (2018-2029)
2.5 Europe Tumor Immunotherapy Drugs Consumption (2018-2029)
2.6 Japan Tumor Immunotherapy Drugs Consumption (2018-2029)
2.7 South Korea Tumor Immunotherapy Drugs Consumption (2018-2029)
2.8 ASEAN Tumor Immunotherapy Drugs Consumption (2018-2029)
2.9 India Tumor Immunotherapy Drugs Consumption (2018-2029)
3 WORLD TUMOR IMMUNOTHERAPY DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Tumor Immunotherapy Drugs Production Value by Manufacturer (2018-2023)
3.2 World Tumor Immunotherapy Drugs Production by Manufacturer (2018-2023)
3.3 World Tumor Immunotherapy Drugs Average Price by Manufacturer (2018-2023)
3.4 Tumor Immunotherapy Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Tumor Immunotherapy Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Tumor Immunotherapy Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for Tumor Immunotherapy Drugs in 2022
3.6 Tumor Immunotherapy Drugs Market: Overall Company Footprint Analysis
3.6.1 Tumor Immunotherapy Drugs Market: Region Footprint
3.6.2 Tumor Immunotherapy Drugs Market: Company Product Type Footprint
3.6.3 Tumor Immunotherapy Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Tumor Immunotherapy Drugs Production Value Comparison
4.1.1 United States VS China: Tumor Immunotherapy Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Tumor Immunotherapy Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Tumor Immunotherapy Drugs Production Comparison
4.2.1 United States VS China: Tumor Immunotherapy Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Tumor Immunotherapy Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Tumor Immunotherapy Drugs Consumption Comparison
4.3.1 United States VS China: Tumor Immunotherapy Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Tumor Immunotherapy Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Tumor Immunotherapy Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Tumor Immunotherapy Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Tumor Immunotherapy Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers Tumor Immunotherapy Drugs Production (2018-2023)
4.5 China Based Tumor Immunotherapy Drugs Manufacturers and Market Share
4.5.1 China Based Tumor Immunotherapy Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Tumor Immunotherapy Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers Tumor Immunotherapy Drugs Production (2018-2023)
4.6 Rest of World Based Tumor Immunotherapy Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Tumor Immunotherapy Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Tumor Immunotherapy Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Tumor Immunotherapy Drugs Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Tumor Immunotherapy Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Immune Checkpoint Inhibitors
5.2.2 Tumor Vaccine
5.2.3 Adoptive Immunotherapy
5.2.4 Non-specific Immunomodulator
5.3 Market Segment by Type
5.3.1 World Tumor Immunotherapy Drugs Production by Type (2018-2029)
5.3.2 World Tumor Immunotherapy Drugs Production Value by Type (2018-2029)
5.3.3 World Tumor Immunotherapy Drugs Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Tumor Immunotherapy Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Tumor Immunotherapy Drugs Production by Application (2018-2029)
6.3.2 World Tumor Immunotherapy Drugs Production Value by Application (2018-2029)
6.3.3 World Tumor Immunotherapy Drugs Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Bristol Myer Squibb
7.1.1 Bristol Myer Squibb Details
7.1.2 Bristol Myer Squibb Major Business
7.1.3 Bristol Myer Squibb Tumor Immunotherapy Drugs Product and Services
7.1.4 Bristol Myer Squibb Tumor Immunotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Bristol Myer Squibb Recent Developments/Updates
7.1.6 Bristol Myer Squibb Competitive Strengths & Weaknesses
7.2 AstraZeneca
7.2.1 AstraZeneca Details
7.2.2 AstraZeneca Major Business
7.2.3 AstraZeneca Tumor Immunotherapy Drugs Product and Services
7.2.4 AstraZeneca Tumor Immunotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 AstraZeneca Recent Developments/Updates
7.2.6 AstraZeneca Competitive Strengths & Weaknesses
7.3 Merck
7.3.1 Merck Details
7.3.2 Merck Major Business
7.3.3 Merck Tumor Immunotherapy Drugs Product and Services
7.3.4 Merck Tumor Immunotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Merck Recent Developments/Updates
7.3.6 Merck Competitive Strengths & Weaknesses
7.4 Roche / Genentech
7.4.1 Roche / Genentech Details
7.4.2 Roche / Genentech Major Business
7.4.3 Roche / Genentech Tumor Immunotherapy Drugs Product and Services
7.4.4 Roche / Genentech Tumor Immunotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Roche / Genentech Recent Developments/Updates
7.4.6 Roche / Genentech Competitive Strengths & Weaknesses
7.5 Ono Pharmaceutical
7.5.1 Ono Pharmaceutical Details
7.5.2 Ono Pharmaceutical Major Business
7.5.3 Ono Pharmaceutical Tumor Immunotherapy Drugs Product and Services
7.5.4 Ono Pharmaceutical Tumor Immunotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Ono Pharmaceutical Recent Developments/Updates
7.5.6 Ono Pharmaceutical Competitive Strengths & Weaknesses
7.6 Regeneron
7.6.1 Regeneron Details
7.6.2 Regeneron Major Business
7.6.3 Regeneron Tumor Immunotherapy Drugs Product and Services
7.6.4 Regeneron Tumor Immunotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Regeneron Recent Developments/Updates
7.6.6 Regeneron Competitive Strengths & Weaknesses
7.7 Innovent
7.7.1 Innovent Details
7.7.2 Innovent Major Business
7.7.3 Innovent Tumor Immunotherapy Drugs Product and Services
7.7.4 Innovent Tumor Immunotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Innovent Recent Developments/Updates
7.7.6 Innovent Competitive Strengths & Weaknesses
7.8 Hengrui Medicine
7.8.1 Hengrui Medicine Details
7.8.2 Hengrui Medicine Major Business
7.8.3 Hengrui Medicine Tumor Immunotherapy Drugs Product and Services
7.8.4 Hengrui Medicine Tumor Immunotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Hengrui Medicine Recent Developments/Updates
7.8.6 Hengrui Medicine Competitive Strengths & Weaknesses
7.9 Junshi Biosciences
7.9.1 Junshi Biosciences Details
7.9.2 Junshi Biosciences Major Business
7.9.3 Junshi Biosciences Tumor Immunotherapy Drugs Product and Services
7.9.4 Junshi Biosciences Tumor Immunotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Junshi Biosciences Recent Developments/Updates
7.9.6 Junshi Biosciences Competitive Strengths & Weaknesses
7.10 Pfizer, Inc
7.10.1 Pfizer, Inc Details
7.10.2 Pfizer, Inc Major Business
7.10.3 Pfizer, Inc Tumor Immunotherapy Drugs Product and Services
7.10.4 Pfizer, Inc Tumor Immunotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Pfizer, Inc Recent Developments/Updates
7.10.6 Pfizer, Inc Competitive Strengths & Weaknesses
7.11 F. Hoffmann-La Roche Ltd
7.11.1 F. Hoffmann-La Roche Ltd Details
7.11.2 F. Hoffmann-La Roche Ltd Major Business
7.11.3 F. Hoffmann-La Roche Ltd Tumor Immunotherapy Drugs Product and Services
7.11.4 F. Hoffmann-La Roche Ltd Tumor Immunotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
7.11.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.12 Incyte Corporation
7.12.1 Incyte Corporation Details
7.12.2 Incyte Corporation Major Business
7.12.3 Incyte Corporation Tumor Immunotherapy Drugs Product and Services
7.12.4 Incyte Corporation Tumor Immunotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Incyte Corporation Recent Developments/Updates
7.12.6 Incyte Corporation Competitive Strengths & Weaknesses
7.13 NewLink Genetics Corporation
7.13.1 NewLink Genetics Corporation Details
7.13.2 NewLink Genetics Corporation Major Business
7.13.3 NewLink Genetics Corporation Tumor Immunotherapy Drugs Product and Services
7.13.4 NewLink Genetics Corporation Tumor Immunotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 NewLink Genetics Corporation Recent Developments/Updates
7.13.6 NewLink Genetics Corporation Competitive Strengths & Weaknesses
7.14 Celldex Therapeutics, Inc
7.14.1 Celldex Therapeutics, Inc Details
7.14.2 Celldex Therapeutics, Inc Major Business
7.14.3 Celldex Therapeutics, Inc Tumor Immunotherapy Drugs Product and Services
7.14.4 Celldex Therapeutics, Inc Tumor Immunotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Celldex Therapeutics, Inc Recent Developments/Updates
7.14.6 Celldex Therapeutics, Inc Competitive Strengths & Weaknesses
7.15 GlaxoSmithKline
7.15.1 GlaxoSmithKline Details
7.15.2 GlaxoSmithKline Major Business
7.15.3 GlaxoSmithKline Tumor Immunotherapy Drugs Product and Services
7.15.4 GlaxoSmithKline Tumor Immunotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 GlaxoSmithKline Recent Developments/Updates
7.15.6 GlaxoSmithKline Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Tumor Immunotherapy Drugs Industry Chain
8.2 Tumor Immunotherapy Drugs Upstream Analysis
8.2.1 Tumor Immunotherapy Drugs Core Raw Materials
8.2.2 Main Manufacturers of Tumor Immunotherapy Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Tumor Immunotherapy Drugs Production Mode
8.6 Tumor Immunotherapy Drugs Procurement Model
8.7 Tumor Immunotherapy Drugs Industry Sales Model and Sales Channels
8.7.1 Tumor Immunotherapy Drugs Sales Model
8.7.2 Tumor Immunotherapy Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Tumor Immunotherapy Drugs Introduction
1.2 World Tumor Immunotherapy Drugs Supply & Forecast
1.2.1 World Tumor Immunotherapy Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World Tumor Immunotherapy Drugs Production (2018-2029)
1.2.3 World Tumor Immunotherapy Drugs Pricing Trends (2018-2029)
1.3 World Tumor Immunotherapy Drugs Production by Region (Based on Production Site)
1.3.1 World Tumor Immunotherapy Drugs Production Value by Region (2018-2029)
1.3.2 World Tumor Immunotherapy Drugs Production by Region (2018-2029)
1.3.3 World Tumor Immunotherapy Drugs Average Price by Region (2018-2029)
1.3.4 North America Tumor Immunotherapy Drugs Production (2018-2029)
1.3.5 Europe Tumor Immunotherapy Drugs Production (2018-2029)
1.3.6 China Tumor Immunotherapy Drugs Production (2018-2029)
1.3.7 Japan Tumor Immunotherapy Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Tumor Immunotherapy Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Tumor Immunotherapy Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Tumor Immunotherapy Drugs Demand (2018-2029)
2.2 World Tumor Immunotherapy Drugs Consumption by Region
2.2.1 World Tumor Immunotherapy Drugs Consumption by Region (2018-2023)
2.2.2 World Tumor Immunotherapy Drugs Consumption Forecast by Region (2024-2029)
2.3 United States Tumor Immunotherapy Drugs Consumption (2018-2029)
2.4 China Tumor Immunotherapy Drugs Consumption (2018-2029)
2.5 Europe Tumor Immunotherapy Drugs Consumption (2018-2029)
2.6 Japan Tumor Immunotherapy Drugs Consumption (2018-2029)
2.7 South Korea Tumor Immunotherapy Drugs Consumption (2018-2029)
2.8 ASEAN Tumor Immunotherapy Drugs Consumption (2018-2029)
2.9 India Tumor Immunotherapy Drugs Consumption (2018-2029)
3 WORLD TUMOR IMMUNOTHERAPY DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Tumor Immunotherapy Drugs Production Value by Manufacturer (2018-2023)
3.2 World Tumor Immunotherapy Drugs Production by Manufacturer (2018-2023)
3.3 World Tumor Immunotherapy Drugs Average Price by Manufacturer (2018-2023)
3.4 Tumor Immunotherapy Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Tumor Immunotherapy Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Tumor Immunotherapy Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for Tumor Immunotherapy Drugs in 2022
3.6 Tumor Immunotherapy Drugs Market: Overall Company Footprint Analysis
3.6.1 Tumor Immunotherapy Drugs Market: Region Footprint
3.6.2 Tumor Immunotherapy Drugs Market: Company Product Type Footprint
3.6.3 Tumor Immunotherapy Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Tumor Immunotherapy Drugs Production Value Comparison
4.1.1 United States VS China: Tumor Immunotherapy Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Tumor Immunotherapy Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Tumor Immunotherapy Drugs Production Comparison
4.2.1 United States VS China: Tumor Immunotherapy Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Tumor Immunotherapy Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Tumor Immunotherapy Drugs Consumption Comparison
4.3.1 United States VS China: Tumor Immunotherapy Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Tumor Immunotherapy Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Tumor Immunotherapy Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Tumor Immunotherapy Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Tumor Immunotherapy Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers Tumor Immunotherapy Drugs Production (2018-2023)
4.5 China Based Tumor Immunotherapy Drugs Manufacturers and Market Share
4.5.1 China Based Tumor Immunotherapy Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Tumor Immunotherapy Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers Tumor Immunotherapy Drugs Production (2018-2023)
4.6 Rest of World Based Tumor Immunotherapy Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Tumor Immunotherapy Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Tumor Immunotherapy Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Tumor Immunotherapy Drugs Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Tumor Immunotherapy Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Immune Checkpoint Inhibitors
5.2.2 Tumor Vaccine
5.2.3 Adoptive Immunotherapy
5.2.4 Non-specific Immunomodulator
5.3 Market Segment by Type
5.3.1 World Tumor Immunotherapy Drugs Production by Type (2018-2029)
5.3.2 World Tumor Immunotherapy Drugs Production Value by Type (2018-2029)
5.3.3 World Tumor Immunotherapy Drugs Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Tumor Immunotherapy Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Tumor Immunotherapy Drugs Production by Application (2018-2029)
6.3.2 World Tumor Immunotherapy Drugs Production Value by Application (2018-2029)
6.3.3 World Tumor Immunotherapy Drugs Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Bristol Myer Squibb
7.1.1 Bristol Myer Squibb Details
7.1.2 Bristol Myer Squibb Major Business
7.1.3 Bristol Myer Squibb Tumor Immunotherapy Drugs Product and Services
7.1.4 Bristol Myer Squibb Tumor Immunotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Bristol Myer Squibb Recent Developments/Updates
7.1.6 Bristol Myer Squibb Competitive Strengths & Weaknesses
7.2 AstraZeneca
7.2.1 AstraZeneca Details
7.2.2 AstraZeneca Major Business
7.2.3 AstraZeneca Tumor Immunotherapy Drugs Product and Services
7.2.4 AstraZeneca Tumor Immunotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 AstraZeneca Recent Developments/Updates
7.2.6 AstraZeneca Competitive Strengths & Weaknesses
7.3 Merck
7.3.1 Merck Details
7.3.2 Merck Major Business
7.3.3 Merck Tumor Immunotherapy Drugs Product and Services
7.3.4 Merck Tumor Immunotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Merck Recent Developments/Updates
7.3.6 Merck Competitive Strengths & Weaknesses
7.4 Roche / Genentech
7.4.1 Roche / Genentech Details
7.4.2 Roche / Genentech Major Business
7.4.3 Roche / Genentech Tumor Immunotherapy Drugs Product and Services
7.4.4 Roche / Genentech Tumor Immunotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Roche / Genentech Recent Developments/Updates
7.4.6 Roche / Genentech Competitive Strengths & Weaknesses
7.5 Ono Pharmaceutical
7.5.1 Ono Pharmaceutical Details
7.5.2 Ono Pharmaceutical Major Business
7.5.3 Ono Pharmaceutical Tumor Immunotherapy Drugs Product and Services
7.5.4 Ono Pharmaceutical Tumor Immunotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Ono Pharmaceutical Recent Developments/Updates
7.5.6 Ono Pharmaceutical Competitive Strengths & Weaknesses
7.6 Regeneron
7.6.1 Regeneron Details
7.6.2 Regeneron Major Business
7.6.3 Regeneron Tumor Immunotherapy Drugs Product and Services
7.6.4 Regeneron Tumor Immunotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Regeneron Recent Developments/Updates
7.6.6 Regeneron Competitive Strengths & Weaknesses
7.7 Innovent
7.7.1 Innovent Details
7.7.2 Innovent Major Business
7.7.3 Innovent Tumor Immunotherapy Drugs Product and Services
7.7.4 Innovent Tumor Immunotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Innovent Recent Developments/Updates
7.7.6 Innovent Competitive Strengths & Weaknesses
7.8 Hengrui Medicine
7.8.1 Hengrui Medicine Details
7.8.2 Hengrui Medicine Major Business
7.8.3 Hengrui Medicine Tumor Immunotherapy Drugs Product and Services
7.8.4 Hengrui Medicine Tumor Immunotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Hengrui Medicine Recent Developments/Updates
7.8.6 Hengrui Medicine Competitive Strengths & Weaknesses
7.9 Junshi Biosciences
7.9.1 Junshi Biosciences Details
7.9.2 Junshi Biosciences Major Business
7.9.3 Junshi Biosciences Tumor Immunotherapy Drugs Product and Services
7.9.4 Junshi Biosciences Tumor Immunotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Junshi Biosciences Recent Developments/Updates
7.9.6 Junshi Biosciences Competitive Strengths & Weaknesses
7.10 Pfizer, Inc
7.10.1 Pfizer, Inc Details
7.10.2 Pfizer, Inc Major Business
7.10.3 Pfizer, Inc Tumor Immunotherapy Drugs Product and Services
7.10.4 Pfizer, Inc Tumor Immunotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Pfizer, Inc Recent Developments/Updates
7.10.6 Pfizer, Inc Competitive Strengths & Weaknesses
7.11 F. Hoffmann-La Roche Ltd
7.11.1 F. Hoffmann-La Roche Ltd Details
7.11.2 F. Hoffmann-La Roche Ltd Major Business
7.11.3 F. Hoffmann-La Roche Ltd Tumor Immunotherapy Drugs Product and Services
7.11.4 F. Hoffmann-La Roche Ltd Tumor Immunotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
7.11.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.12 Incyte Corporation
7.12.1 Incyte Corporation Details
7.12.2 Incyte Corporation Major Business
7.12.3 Incyte Corporation Tumor Immunotherapy Drugs Product and Services
7.12.4 Incyte Corporation Tumor Immunotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Incyte Corporation Recent Developments/Updates
7.12.6 Incyte Corporation Competitive Strengths & Weaknesses
7.13 NewLink Genetics Corporation
7.13.1 NewLink Genetics Corporation Details
7.13.2 NewLink Genetics Corporation Major Business
7.13.3 NewLink Genetics Corporation Tumor Immunotherapy Drugs Product and Services
7.13.4 NewLink Genetics Corporation Tumor Immunotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 NewLink Genetics Corporation Recent Developments/Updates
7.13.6 NewLink Genetics Corporation Competitive Strengths & Weaknesses
7.14 Celldex Therapeutics, Inc
7.14.1 Celldex Therapeutics, Inc Details
7.14.2 Celldex Therapeutics, Inc Major Business
7.14.3 Celldex Therapeutics, Inc Tumor Immunotherapy Drugs Product and Services
7.14.4 Celldex Therapeutics, Inc Tumor Immunotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Celldex Therapeutics, Inc Recent Developments/Updates
7.14.6 Celldex Therapeutics, Inc Competitive Strengths & Weaknesses
7.15 GlaxoSmithKline
7.15.1 GlaxoSmithKline Details
7.15.2 GlaxoSmithKline Major Business
7.15.3 GlaxoSmithKline Tumor Immunotherapy Drugs Product and Services
7.15.4 GlaxoSmithKline Tumor Immunotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 GlaxoSmithKline Recent Developments/Updates
7.15.6 GlaxoSmithKline Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Tumor Immunotherapy Drugs Industry Chain
8.2 Tumor Immunotherapy Drugs Upstream Analysis
8.2.1 Tumor Immunotherapy Drugs Core Raw Materials
8.2.2 Main Manufacturers of Tumor Immunotherapy Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Tumor Immunotherapy Drugs Production Mode
8.6 Tumor Immunotherapy Drugs Procurement Model
8.7 Tumor Immunotherapy Drugs Industry Sales Model and Sales Channels
8.7.1 Tumor Immunotherapy Drugs Sales Model
8.7.2 Tumor Immunotherapy Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Tumor Immunotherapy Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Tumor Immunotherapy Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World Tumor Immunotherapy Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World Tumor Immunotherapy Drugs Production Value Market Share by Region (2018-2023)
Table 5. World Tumor Immunotherapy Drugs Production Value Market Share by Region (2024-2029)
Table 6. World Tumor Immunotherapy Drugs Production by Region (2018-2023) & (K Units)
Table 7. World Tumor Immunotherapy Drugs Production by Region (2024-2029) & (K Units)
Table 8. World Tumor Immunotherapy Drugs Production Market Share by Region (2018-2023)
Table 9. World Tumor Immunotherapy Drugs Production Market Share by Region (2024-2029)
Table 10. World Tumor Immunotherapy Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Tumor Immunotherapy Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Tumor Immunotherapy Drugs Major Market Trends
Table 13. World Tumor Immunotherapy Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Tumor Immunotherapy Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World Tumor Immunotherapy Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Tumor Immunotherapy Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Tumor Immunotherapy Drugs Producers in 2022
Table 18. World Tumor Immunotherapy Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Tumor Immunotherapy Drugs Producers in 2022
Table 20. World Tumor Immunotherapy Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Tumor Immunotherapy Drugs Company Evaluation Quadrant
Table 22. World Tumor Immunotherapy Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Tumor Immunotherapy Drugs Production Site of Key Manufacturer
Table 24. Tumor Immunotherapy Drugs Market: Company Product Type Footprint
Table 25. Tumor Immunotherapy Drugs Market: Company Product Application Footprint
Table 26. Tumor Immunotherapy Drugs Competitive Factors
Table 27. Tumor Immunotherapy Drugs New Entrant and Capacity Expansion Plans
Table 28. Tumor Immunotherapy Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Tumor Immunotherapy Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Tumor Immunotherapy Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Tumor Immunotherapy Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Tumor Immunotherapy Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Tumor Immunotherapy Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Tumor Immunotherapy Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Tumor Immunotherapy Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Tumor Immunotherapy Drugs Production Market Share (2018-2023)
Table 37. China Based Tumor Immunotherapy Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Tumor Immunotherapy Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Tumor Immunotherapy Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Tumor Immunotherapy Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Tumor Immunotherapy Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based Tumor Immunotherapy Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Tumor Immunotherapy Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Tumor Immunotherapy Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Tumor Immunotherapy Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Tumor Immunotherapy Drugs Production Market Share (2018-2023)
Table 47. World Tumor Immunotherapy Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Tumor Immunotherapy Drugs Production by Type (2018-2023) & (K Units)
Table 49. World Tumor Immunotherapy Drugs Production by Type (2024-2029) & (K Units)
Table 50. World Tumor Immunotherapy Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World Tumor Immunotherapy Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World Tumor Immunotherapy Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Tumor Immunotherapy Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Tumor Immunotherapy Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Tumor Immunotherapy Drugs Production by Application (2018-2023) & (K Units)
Table 56. World Tumor Immunotherapy Drugs Production by Application (2024-2029) & (K Units)
Table 57. World Tumor Immunotherapy Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World Tumor Immunotherapy Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World Tumor Immunotherapy Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Tumor Immunotherapy Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Bristol Myer Squibb Basic Information, Manufacturing Base and Competitors
Table 62. Bristol Myer Squibb Major Business
Table 63. Bristol Myer Squibb Tumor Immunotherapy Drugs Product and Services
Table 64. Bristol Myer Squibb Tumor Immunotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Bristol Myer Squibb Recent Developments/Updates
Table 66. Bristol Myer Squibb Competitive Strengths & Weaknesses
Table 67. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 68. AstraZeneca Major Business
Table 69. AstraZeneca Tumor Immunotherapy Drugs Product and Services
Table 70. AstraZeneca Tumor Immunotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. AstraZeneca Recent Developments/Updates
Table 72. AstraZeneca Competitive Strengths & Weaknesses
Table 73. Merck Basic Information, Manufacturing Base and Competitors
Table 74. Merck Major Business
Table 75. Merck Tumor Immunotherapy Drugs Product and Services
Table 76. Merck Tumor Immunotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Merck Recent Developments/Updates
Table 78. Merck Competitive Strengths & Weaknesses
Table 79. Roche / Genentech Basic Information, Manufacturing Base and Competitors
Table 80. Roche / Genentech Major Business
Table 81. Roche / Genentech Tumor Immunotherapy Drugs Product and Services
Table 82. Roche / Genentech Tumor Immunotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Roche / Genentech Recent Developments/Updates
Table 84. Roche / Genentech Competitive Strengths & Weaknesses
Table 85. Ono Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 86. Ono Pharmaceutical Major Business
Table 87. Ono Pharmaceutical Tumor Immunotherapy Drugs Product and Services
Table 88. Ono Pharmaceutical Tumor Immunotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Ono Pharmaceutical Recent Developments/Updates
Table 90. Ono Pharmaceutical Competitive Strengths & Weaknesses
Table 91. Regeneron Basic Information, Manufacturing Base and Competitors
Table 92. Regeneron Major Business
Table 93. Regeneron Tumor Immunotherapy Drugs Product and Services
Table 94. Regeneron Tumor Immunotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Regeneron Recent Developments/Updates
Table 96. Regeneron Competitive Strengths & Weaknesses
Table 97. Innovent Basic Information, Manufacturing Base and Competitors
Table 98. Innovent Major Business
Table 99. Innovent Tumor Immunotherapy Drugs Product and Services
Table 100. Innovent Tumor Immunotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Innovent Recent Developments/Updates
Table 102. Innovent Competitive Strengths & Weaknesses
Table 103. Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 104. Hengrui Medicine Major Business
Table 105. Hengrui Medicine Tumor Immunotherapy Drugs Product and Services
Table 106. Hengrui Medicine Tumor Immunotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Hengrui Medicine Recent Developments/Updates
Table 108. Hengrui Medicine Competitive Strengths & Weaknesses
Table 109. Junshi Biosciences Basic Information, Manufacturing Base and Competitors
Table 110. Junshi Biosciences Major Business
Table 111. Junshi Biosciences Tumor Immunotherapy Drugs Product and Services
Table 112. Junshi Biosciences Tumor Immunotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Junshi Biosciences Recent Developments/Updates
Table 114. Junshi Biosciences Competitive Strengths & Weaknesses
Table 115. Pfizer, Inc Basic Information, Manufacturing Base and Competitors
Table 116. Pfizer, Inc Major Business
Table 117. Pfizer, Inc Tumor Immunotherapy Drugs Product and Services
Table 118. Pfizer, Inc Tumor Immunotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Pfizer, Inc Recent Developments/Updates
Table 120. Pfizer, Inc Competitive Strengths & Weaknesses
Table 121. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 122. F. Hoffmann-La Roche Ltd Major Business
Table 123. F. Hoffmann-La Roche Ltd Tumor Immunotherapy Drugs Product and Services
Table 124. F. Hoffmann-La Roche Ltd Tumor Immunotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 126. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 127. Incyte Corporation Basic Information, Manufacturing Base and Competitors
Table 128. Incyte Corporation Major Business
Table 129. Incyte Corporation Tumor Immunotherapy Drugs Product and Services
Table 130. Incyte Corporation Tumor Immunotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Incyte Corporation Recent Developments/Updates
Table 132. Incyte Corporation Competitive Strengths & Weaknesses
Table 133. NewLink Genetics Corporation Basic Information, Manufacturing Base and Competitors
Table 134. NewLink Genetics Corporation Major Business
Table 135. NewLink Genetics Corporation Tumor Immunotherapy Drugs Product and Services
Table 136. NewLink Genetics Corporation Tumor Immunotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. NewLink Genetics Corporation Recent Developments/Updates
Table 138. NewLink Genetics Corporation Competitive Strengths & Weaknesses
Table 139. Celldex Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table 140. Celldex Therapeutics, Inc Major Business
Table 141. Celldex Therapeutics, Inc Tumor Immunotherapy Drugs Product and Services
Table 142. Celldex Therapeutics, Inc Tumor Immunotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Celldex Therapeutics, Inc Recent Developments/Updates
Table 144. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 145. GlaxoSmithKline Major Business
Table 146. GlaxoSmithKline Tumor Immunotherapy Drugs Product and Services
Table 147. GlaxoSmithKline Tumor Immunotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Tumor Immunotherapy Drugs Upstream (Raw Materials)
Table 149. Tumor Immunotherapy Drugs Typical Customers
Table 150. Tumor Immunotherapy Drugs Typical Distributors
List of Figure
Figure 1. Tumor Immunotherapy Drugs Picture
Figure 2. World Tumor Immunotherapy Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Tumor Immunotherapy Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Tumor Immunotherapy Drugs Production (2018-2029) & (K Units)
Figure 5. World Tumor Immunotherapy Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World Tumor Immunotherapy Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World Tumor Immunotherapy Drugs Production Market Share by Region (2018-2029)
Figure 8. North America Tumor Immunotherapy Drugs Production (2018-2029) & (K Units)
Figure 9. Europe Tumor Immunotherapy Drugs Production (2018-2029) & (K Units)
Figure 10. China Tumor Immunotherapy Drugs Production (2018-2029) & (K Units)
Figure 11. Japan Tumor Immunotherapy Drugs Production (2018-2029) & (K Units)
Figure 12. Tumor Immunotherapy Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Tumor Immunotherapy Drugs Consumption (2018-2029) & (K Units)
Figure 15. World Tumor Immunotherapy Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States Tumor Immunotherapy Drugs Consumption (2018-2029) & (K Units)
Figure 17. China Tumor Immunotherapy Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe Tumor Immunotherapy Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan Tumor Immunotherapy Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea Tumor Immunotherapy Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Tumor Immunotherapy Drugs Consumption (2018-2029) & (K Units)
Figure 22. India Tumor Immunotherapy Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Tumor Immunotherapy Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Tumor Immunotherapy Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Tumor Immunotherapy Drugs Markets in 2022
Figure 26. United States VS China: Tumor Immunotherapy Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Tumor Immunotherapy Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Tumor Immunotherapy Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Tumor Immunotherapy Drugs Production Market Share 2022
Figure 30. China Based Manufacturers Tumor Immunotherapy Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Tumor Immunotherapy Drugs Production Market Share 2022
Figure 32. World Tumor Immunotherapy Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Tumor Immunotherapy Drugs Production Value Market Share by Type in 2022
Figure 34. Immune Checkpoint Inhibitors
Figure 35. Tumor Vaccine
Figure 36. Adoptive Immunotherapy
Figure 37. Non-specific Immunomodulator
Figure 38. World Tumor Immunotherapy Drugs Production Market Share by Type (2018-2029)
Figure 39. World Tumor Immunotherapy Drugs Production Value Market Share by Type (2018-2029)
Figure 40. World Tumor Immunotherapy Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Tumor Immunotherapy Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Tumor Immunotherapy Drugs Production Value Market Share by Application in 2022
Figure 43. Hospital
Figure 44. Clinic
Figure 45. Other
Figure 46. World Tumor Immunotherapy Drugs Production Market Share by Application (2018-2029)
Figure 47. World Tumor Immunotherapy Drugs Production Value Market Share by Application (2018-2029)
Figure 48. World Tumor Immunotherapy Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. Tumor Immunotherapy Drugs Industry Chain
Figure 50. Tumor Immunotherapy Drugs Procurement Model
Figure 51. Tumor Immunotherapy Drugs Sales Model
Figure 52. Tumor Immunotherapy Drugs Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
Table 1. World Tumor Immunotherapy Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Tumor Immunotherapy Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World Tumor Immunotherapy Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World Tumor Immunotherapy Drugs Production Value Market Share by Region (2018-2023)
Table 5. World Tumor Immunotherapy Drugs Production Value Market Share by Region (2024-2029)
Table 6. World Tumor Immunotherapy Drugs Production by Region (2018-2023) & (K Units)
Table 7. World Tumor Immunotherapy Drugs Production by Region (2024-2029) & (K Units)
Table 8. World Tumor Immunotherapy Drugs Production Market Share by Region (2018-2023)
Table 9. World Tumor Immunotherapy Drugs Production Market Share by Region (2024-2029)
Table 10. World Tumor Immunotherapy Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Tumor Immunotherapy Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Tumor Immunotherapy Drugs Major Market Trends
Table 13. World Tumor Immunotherapy Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Tumor Immunotherapy Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World Tumor Immunotherapy Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Tumor Immunotherapy Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Tumor Immunotherapy Drugs Producers in 2022
Table 18. World Tumor Immunotherapy Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Tumor Immunotherapy Drugs Producers in 2022
Table 20. World Tumor Immunotherapy Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Tumor Immunotherapy Drugs Company Evaluation Quadrant
Table 22. World Tumor Immunotherapy Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Tumor Immunotherapy Drugs Production Site of Key Manufacturer
Table 24. Tumor Immunotherapy Drugs Market: Company Product Type Footprint
Table 25. Tumor Immunotherapy Drugs Market: Company Product Application Footprint
Table 26. Tumor Immunotherapy Drugs Competitive Factors
Table 27. Tumor Immunotherapy Drugs New Entrant and Capacity Expansion Plans
Table 28. Tumor Immunotherapy Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Tumor Immunotherapy Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Tumor Immunotherapy Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Tumor Immunotherapy Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Tumor Immunotherapy Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Tumor Immunotherapy Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Tumor Immunotherapy Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Tumor Immunotherapy Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Tumor Immunotherapy Drugs Production Market Share (2018-2023)
Table 37. China Based Tumor Immunotherapy Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Tumor Immunotherapy Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Tumor Immunotherapy Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Tumor Immunotherapy Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Tumor Immunotherapy Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based Tumor Immunotherapy Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Tumor Immunotherapy Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Tumor Immunotherapy Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Tumor Immunotherapy Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Tumor Immunotherapy Drugs Production Market Share (2018-2023)
Table 47. World Tumor Immunotherapy Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Tumor Immunotherapy Drugs Production by Type (2018-2023) & (K Units)
Table 49. World Tumor Immunotherapy Drugs Production by Type (2024-2029) & (K Units)
Table 50. World Tumor Immunotherapy Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World Tumor Immunotherapy Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World Tumor Immunotherapy Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Tumor Immunotherapy Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Tumor Immunotherapy Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Tumor Immunotherapy Drugs Production by Application (2018-2023) & (K Units)
Table 56. World Tumor Immunotherapy Drugs Production by Application (2024-2029) & (K Units)
Table 57. World Tumor Immunotherapy Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World Tumor Immunotherapy Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World Tumor Immunotherapy Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Tumor Immunotherapy Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Bristol Myer Squibb Basic Information, Manufacturing Base and Competitors
Table 62. Bristol Myer Squibb Major Business
Table 63. Bristol Myer Squibb Tumor Immunotherapy Drugs Product and Services
Table 64. Bristol Myer Squibb Tumor Immunotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Bristol Myer Squibb Recent Developments/Updates
Table 66. Bristol Myer Squibb Competitive Strengths & Weaknesses
Table 67. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 68. AstraZeneca Major Business
Table 69. AstraZeneca Tumor Immunotherapy Drugs Product and Services
Table 70. AstraZeneca Tumor Immunotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. AstraZeneca Recent Developments/Updates
Table 72. AstraZeneca Competitive Strengths & Weaknesses
Table 73. Merck Basic Information, Manufacturing Base and Competitors
Table 74. Merck Major Business
Table 75. Merck Tumor Immunotherapy Drugs Product and Services
Table 76. Merck Tumor Immunotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Merck Recent Developments/Updates
Table 78. Merck Competitive Strengths & Weaknesses
Table 79. Roche / Genentech Basic Information, Manufacturing Base and Competitors
Table 80. Roche / Genentech Major Business
Table 81. Roche / Genentech Tumor Immunotherapy Drugs Product and Services
Table 82. Roche / Genentech Tumor Immunotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Roche / Genentech Recent Developments/Updates
Table 84. Roche / Genentech Competitive Strengths & Weaknesses
Table 85. Ono Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 86. Ono Pharmaceutical Major Business
Table 87. Ono Pharmaceutical Tumor Immunotherapy Drugs Product and Services
Table 88. Ono Pharmaceutical Tumor Immunotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Ono Pharmaceutical Recent Developments/Updates
Table 90. Ono Pharmaceutical Competitive Strengths & Weaknesses
Table 91. Regeneron Basic Information, Manufacturing Base and Competitors
Table 92. Regeneron Major Business
Table 93. Regeneron Tumor Immunotherapy Drugs Product and Services
Table 94. Regeneron Tumor Immunotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Regeneron Recent Developments/Updates
Table 96. Regeneron Competitive Strengths & Weaknesses
Table 97. Innovent Basic Information, Manufacturing Base and Competitors
Table 98. Innovent Major Business
Table 99. Innovent Tumor Immunotherapy Drugs Product and Services
Table 100. Innovent Tumor Immunotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Innovent Recent Developments/Updates
Table 102. Innovent Competitive Strengths & Weaknesses
Table 103. Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 104. Hengrui Medicine Major Business
Table 105. Hengrui Medicine Tumor Immunotherapy Drugs Product and Services
Table 106. Hengrui Medicine Tumor Immunotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Hengrui Medicine Recent Developments/Updates
Table 108. Hengrui Medicine Competitive Strengths & Weaknesses
Table 109. Junshi Biosciences Basic Information, Manufacturing Base and Competitors
Table 110. Junshi Biosciences Major Business
Table 111. Junshi Biosciences Tumor Immunotherapy Drugs Product and Services
Table 112. Junshi Biosciences Tumor Immunotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Junshi Biosciences Recent Developments/Updates
Table 114. Junshi Biosciences Competitive Strengths & Weaknesses
Table 115. Pfizer, Inc Basic Information, Manufacturing Base and Competitors
Table 116. Pfizer, Inc Major Business
Table 117. Pfizer, Inc Tumor Immunotherapy Drugs Product and Services
Table 118. Pfizer, Inc Tumor Immunotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Pfizer, Inc Recent Developments/Updates
Table 120. Pfizer, Inc Competitive Strengths & Weaknesses
Table 121. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 122. F. Hoffmann-La Roche Ltd Major Business
Table 123. F. Hoffmann-La Roche Ltd Tumor Immunotherapy Drugs Product and Services
Table 124. F. Hoffmann-La Roche Ltd Tumor Immunotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 126. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 127. Incyte Corporation Basic Information, Manufacturing Base and Competitors
Table 128. Incyte Corporation Major Business
Table 129. Incyte Corporation Tumor Immunotherapy Drugs Product and Services
Table 130. Incyte Corporation Tumor Immunotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Incyte Corporation Recent Developments/Updates
Table 132. Incyte Corporation Competitive Strengths & Weaknesses
Table 133. NewLink Genetics Corporation Basic Information, Manufacturing Base and Competitors
Table 134. NewLink Genetics Corporation Major Business
Table 135. NewLink Genetics Corporation Tumor Immunotherapy Drugs Product and Services
Table 136. NewLink Genetics Corporation Tumor Immunotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. NewLink Genetics Corporation Recent Developments/Updates
Table 138. NewLink Genetics Corporation Competitive Strengths & Weaknesses
Table 139. Celldex Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table 140. Celldex Therapeutics, Inc Major Business
Table 141. Celldex Therapeutics, Inc Tumor Immunotherapy Drugs Product and Services
Table 142. Celldex Therapeutics, Inc Tumor Immunotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Celldex Therapeutics, Inc Recent Developments/Updates
Table 144. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 145. GlaxoSmithKline Major Business
Table 146. GlaxoSmithKline Tumor Immunotherapy Drugs Product and Services
Table 147. GlaxoSmithKline Tumor Immunotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Tumor Immunotherapy Drugs Upstream (Raw Materials)
Table 149. Tumor Immunotherapy Drugs Typical Customers
Table 150. Tumor Immunotherapy Drugs Typical Distributors
List of Figure
Figure 1. Tumor Immunotherapy Drugs Picture
Figure 2. World Tumor Immunotherapy Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Tumor Immunotherapy Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Tumor Immunotherapy Drugs Production (2018-2029) & (K Units)
Figure 5. World Tumor Immunotherapy Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World Tumor Immunotherapy Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World Tumor Immunotherapy Drugs Production Market Share by Region (2018-2029)
Figure 8. North America Tumor Immunotherapy Drugs Production (2018-2029) & (K Units)
Figure 9. Europe Tumor Immunotherapy Drugs Production (2018-2029) & (K Units)
Figure 10. China Tumor Immunotherapy Drugs Production (2018-2029) & (K Units)
Figure 11. Japan Tumor Immunotherapy Drugs Production (2018-2029) & (K Units)
Figure 12. Tumor Immunotherapy Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Tumor Immunotherapy Drugs Consumption (2018-2029) & (K Units)
Figure 15. World Tumor Immunotherapy Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States Tumor Immunotherapy Drugs Consumption (2018-2029) & (K Units)
Figure 17. China Tumor Immunotherapy Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe Tumor Immunotherapy Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan Tumor Immunotherapy Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea Tumor Immunotherapy Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Tumor Immunotherapy Drugs Consumption (2018-2029) & (K Units)
Figure 22. India Tumor Immunotherapy Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Tumor Immunotherapy Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Tumor Immunotherapy Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Tumor Immunotherapy Drugs Markets in 2022
Figure 26. United States VS China: Tumor Immunotherapy Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Tumor Immunotherapy Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Tumor Immunotherapy Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Tumor Immunotherapy Drugs Production Market Share 2022
Figure 30. China Based Manufacturers Tumor Immunotherapy Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Tumor Immunotherapy Drugs Production Market Share 2022
Figure 32. World Tumor Immunotherapy Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Tumor Immunotherapy Drugs Production Value Market Share by Type in 2022
Figure 34. Immune Checkpoint Inhibitors
Figure 35. Tumor Vaccine
Figure 36. Adoptive Immunotherapy
Figure 37. Non-specific Immunomodulator
Figure 38. World Tumor Immunotherapy Drugs Production Market Share by Type (2018-2029)
Figure 39. World Tumor Immunotherapy Drugs Production Value Market Share by Type (2018-2029)
Figure 40. World Tumor Immunotherapy Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Tumor Immunotherapy Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Tumor Immunotherapy Drugs Production Value Market Share by Application in 2022
Figure 43. Hospital
Figure 44. Clinic
Figure 45. Other
Figure 46. World Tumor Immunotherapy Drugs Production Market Share by Application (2018-2029)
Figure 47. World Tumor Immunotherapy Drugs Production Value Market Share by Application (2018-2029)
Figure 48. World Tumor Immunotherapy Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. Tumor Immunotherapy Drugs Industry Chain
Figure 50. Tumor Immunotherapy Drugs Procurement Model
Figure 51. Tumor Immunotherapy Drugs Sales Model
Figure 52. Tumor Immunotherapy Drugs Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
